(Q34415834)

English

Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Impact of the Food and Drug Administration approval of flecainide and encainide on coronary artery disease mortality: putting "Deadly Medicine" to the test (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Anderson JL

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pratt CM

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Waldo AL

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Karagounis LA

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

43-47

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

The Cardiac Arrhythmia Suppression Trial. Introduction: The aftermath of the CAST--a reconsideration of traditional concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

The Cardiac Arrhythmia Suppression Trial: background, interim results and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

A perspective on ventricular arrhythmias: patient assessment for therapy and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

The cardiac arrhythmia suppression trial: implications for antiarrhythmic drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Reassessment of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Malignant ventricular tachyarrhythmias associated with the use of encainide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

The healthy responder phenomenon in non-randomized clinical trials. CAST Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Association between ease of suppression of ventricular arrhythmia and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900673-X

7 January 2021

Identifiers

10.1016/S0002-9149(96)00673-X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34415834&oldid=1980546331"